Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $21 Million - $22.9 Million
-209,600 Reduced 90.38%
22,300 $2.43 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $25.2 Million - $27.5 Million
231,900 New
231,900 $26.8 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $50.7 Million - $57 Million
600,000 New
600,000 $51.7 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $76.6 Million - $86.8 Million
-917,500 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $13.4 Million - $15 Million
-182,500 Reduced 16.59%
917,500 $75.3 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $35.8 Million - $39.4 Million
500,000 Added 83.33%
1,100,000 $82.6 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $29.2 Million - $32.3 Million
415,000 Added 224.32%
600,000 $46.7 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $13.3 Million - $14.7 Million
185,000 New
185,000 $15.1 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $73.6 Million - $83.4 Million
-1,005,300 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $68.7 Million - $78.2 Million
975,300 Added 3251.0%
1,005,300 $77.7 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $37.6 Million - $42.5 Million
-485,000 Reduced 94.17%
30,000 $2.73 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $34 Million - $37.1 Million
447,000 Added 657.35%
515,000 $43.4 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $1.73 Million - $2.04 Million
30,000 Added 78.95%
68,000 $4.82 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $2.8 Million - $3.26 Million
-55,000 Reduced 59.14%
38,000 $2.07 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $5.46 Million - $5.87 Million
93,000
93,000 $5.96 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.